Use of diuretics in cardiovascular diseases: (1) Heart failure

Postgraduate Medical Journal

Volumn 80, Issue 942, 2004, Pages 201-205

  Shah, S U ^a,b   Anjum, S ^c   Littler, W A ^d  

^a University of Birmingham ^*  (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c GLAN CLWYD HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BENDROFLUMETHIAZIDE; BENZOTHIADIAZINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; CANRENOATE POTASSIUM; CHLOROTHIAZIDE; CHLORTALIDONE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETACRYNIC ACID; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LAXATIVE; LOOP DIURETIC AGENT; METOLAZONE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; TORASEMIDE; TRIAMTERENE; XANTHINE OXIDASE INHIBITOR;

BLOOD DYSCRASIA; CARDIOVASCULAR DISEASE; COMMUNITY CARE; DEHYDRATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG CLASSIFICATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG UTILIZATION; HEART FAILURE; HOSPITAL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERURICEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; IMPOTENCE; KIDNEY; MEDICAL PRACTICE; OTOTOXICITY; PANCREATITIS; REVIEW; SYMPTOM; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

CHRONIC DISEASE; DIURETICS; DRUG RESISTANCE; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 2342435704     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2003.010835     Document Type: Review

References (45)

1. Opie LH, Gersh BJ. Diuretics. In: Opie LH, Gersh BJ, eds. Drugs for the heart. 5th Ed. Philadelphia: WB Saunders, 2001:84-106.
2. Reyes AJ, Taylor SH. Diuretics in cardiovascular therapy: the new clinicopharmacological boses that matter. Cardiavasc Drugs Ther 1999;13:371-98.
3. Dikshit K, Vyden JK, Forrester JS, et al. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 1973;288:1087-90.
4. Gamba G, Saltzberg SN, Lombardi M, et al. Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride catransporter. Proc Natl Acad Sci USA 1993;90:2749-53.
5. Brater DC. Diuretic therapy. N Engl J Med 1998;339:387-95.
6. Brater DC. Pharmacology of diuretics. Am J Med Sci 2000;319:38-50.
7. + channel is made of three homologous subunits. Nature 1994;367:463-7.
8. K) in guinea pig ventricular myocytes. Circ Res 1994;74:1114-20.
9. Wang L, Sheldon RS, Mitchell B, et al. Amiloride-quinidine interaction: adverse outcomes. Clin Pharmacol Ther 1994;56:659-67.
10. 3H)spirolactone (SC-26304). Proc Natl Acad Sci USA 1974;71:1431-5.
11. Pitt B, Zannad F, Remme WJ, et al. The effect of spiranolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17, 974.
12. Silke B. Hemodynamic impact of diuretic therapy in chronic heart failure. Cardiology 1994;84:115-23.
13. Raftery EB. Hemodynamic effects of diuretics in heart failure. Br Heart J 1994;72(suppl 2):44-7S.
14. Greenberg S, McGowon C, Xie J, et al. Selective pulmonary and venous smooth muscle relaxation by furosemide: a comparison with morphine. J Pharmacol Exp Ther 1994;270:1077-85.
15. Wiemer G, Fink E, Linz W, et al. Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin. J Pharmacol Exp Ther 1994;271:1611-15.
16. Pickkers P, Hughes AD, Frans G, et al. Thiazide-induced vasodilation in humans is mediated by potassium channel activation. Hypertension 1998;32:1071-6.
17. Kaplan NM. Diuretics as a basis of antihypertensive therapy. An overview. Drugs 2000;59(suppl 2):21-5.
18. Weir MR, Flack JM, Applegate WB. Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics. Am J Med 1996;101:83-92S.
19. Siscovik DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-7.
20. Kaplan NM, Carnegie A, Raskin P, et al. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med 1985;312:746-9.
21. Dorup I, Skajaa K, Thybo NK. Oral magnesium supplementation restores the concentration of magnesium, potassium, and sodium-potassium pumps in skeletal muscle of patients receiving diuretic treatment. J Intern Med 1993;233:117-23.
22. Waller PC, Ramsay LE. Predicting acute gout in diuretic-treated hypertensive patients. J Hum Hypertens 1989;3:457-61.
23. Lakshman MR, Reda DJ, Materson BJ, et al. Diuretics and beta blackers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Arch Intern Med 1999;159:551-8.
24. Hunter SJ, Harper R, Ennis CN, et al. Effects of combination therapy with an angiotensin converting enzyme inhibitor and thiazide diuretic on insulin action in essential hypertension. J Hypertens 1998;16:103-9.
25. Gesek FA, Friedman PA. Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. J Clin Invest 1992;90:429-38.
26. Morton DJ, Barrett-Connor EL, Edelstein SL. Thiazides and bone mineral density in elderly men and women. Am J Epidemial 1994;139:1107-15.
27. Grimm RH Jr, Grandits GA, Prineas RJ, et al. Long-term effects on sexual function af five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Hypertension 1997;29:8-14.
28. Lee I-M, Hennekens CH. Diuretics and renal cell carcinoma. Am J Cardiol 1999;83:1094.
29. Grossman E, Messerli FH, Galdbourt U. Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol 1999;83:1090-3.
30. Winawer J, Abassi Z, Green J, at al. Control of extracellular fluid volume and the pathophysiology of edema formation. In: Brenner BM, Rector FC, eds. Brenner and Rector's the kidney. 6th Ed. Philadelphia: WB Saunders, 2000:220-65.
31. Schrier RW, Martin PY. Recent advances in the understanding of water metabolism in heart failure. Adv Exp Med Biol 1998;449:415-26.
32. Packer M, Cohn JN. Consensus recommendations for the management of chronic heart failure. Am J Cardiol 1999;83(2A):1-38A.
33. Kiyingi A, Field MJ, Pawsey CC, et al. Metalazone in treatment of severe refractory congestive cardiac failure. Lancet 1990;335:29-31.
34. Dormans TPJ, Gerlag PGG. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 1996;17:1867-74.
35. Vargo D, Kromer WG, Black RK, et al. The pharmocodynamics of torsemide in patients with congestive heart failure. Clin Pharmacol Ther 1994;56:48-54.
36. Brater DC. Diuretic resistance: mechanisms and therapeutic strategies. Cardiology 1994;84(suppl 2):57-67.
37. Gradual NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA 1998;279:1383-91.
38. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984;310:347-52.
39. Morsing P, Velazquez H, Wright FS, et al. Adaptation of distal convoluted tubule of rats. II. Effects of chronic thiazide infusion. Am J Physiol 1991;261:F137-43.
40. Good JM, Brody AJB, Noormohamed FH, et al. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition. Circulation 1994;90:2204.
41. Lahav M, Regev A, Ra'anani P, et al. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest 1992;102:725-31.
42. Ellison DH. The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 1991;114:886-94.
43. Wingo CS, Cain BD. The renal H-K-ATPase: physiological significance and role in potassium homeastasis. Annu Rev Physiol 1993;55:323-47.
44. Weber KT, Villarreal D. Aldosterone and antialdosterone therapy in congestive heart failure (abstract). Am J Cardiol 1993;71:3-11A.
45. Bigger JT Jr. Diuretic therapy, hypertension, and cardiac arrest. N Engl J Med 1994;330:1899-900.